Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Eric Secrist

Orthopaedic Surgery Mount Vernon, WA Medical Doctor

NPI 1760914840 CMS profile 3359846

1500 Continental Pl, Mount Vernon, WA 98273

Open in the dashboard

General payments

$18,208

83 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Eric Secrist of Mount Vernon, WA is reported in the CMS Open Payments database as having received $18,208 across 83 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 78th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,298 16
2024 General $3,054 26
2023 General $5,690 20
2022 General $2,860 7
2021 General $4,973 10
2020 General $140 2
2019 General $192 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Eric Secrist
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Eric Secrist were reported at $1,298. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Eric Secrist Orthopaedic Surgery median Middle half National median
2019 $192 $644 $140–$2,844 $163
2020 $140 $312 $75–$1,860 $114
2021 $4,973 $520 $117–$2,495 $132
2022 $2,860 $598 $128–$2,731 $149
2023 $5,690 $461 $128–$2,264 $160
2024 $3,054 $497 $134–$2,475 $164
2025 $1,298 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Smith+Nephew, Inc. $9,531 29 payments
  2. Peerless Surgical Inc. $5,022 8 payments
  3. Zimmer Biomet Holdings, Inc. $2,136 24 payments
  4. DePuy Synthes Sales Inc. $832 8 payments
  5. Medical Device Business Services, Inc. $234 2 payments
  6. Medtronic USA, Inc. $109 1 payment
  7. Abbott Laboratories $90 1 payment
  8. Acumed LLC $84 1 payment
  9. Stryker Corporation $77 3 payments
  10. DeRoyal Industries, Inc. $29 1 payment
  11. Other $65 5 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Education $8,937 7 payments
  2. Travel and Lodging $5,850 19 payments
  3. Food and Beverage $3,422 57 payments
Products named General payments · program years 2019–2025
  1. LEGION Revision $2,526 10 payments
  2. REDAPT $2,379 7 payments
  3. JOURNEY II Recon Knees $2,019 10 payments
  4. JOURNEY II Recon Knees $1,915 9 payments
  5. POLARCUP $1,802 6 payments
  6. REAL INTELLIGENCE $1,743 12 payments
  7. TANDEM $1,174 4 payments
  8. Avenir $681 3 payments
  9. PICO $598 3 payments
  10. RI Hip Navigation $598 3 payments
  11. Other $1,927 43 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 5 drugs

Part D claims

156

Median for Orthopedic Surgery: 203

Drug cost

$1,016

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Mupirocin Generic 51 $358
Celecoxib Generic 21 $332
Meloxicam Generic 53 $225
Oxycodone Hcl Generic 14 $81
Amoxicillin Generic 17 $20

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 70 billing codes

Paid by Medicare

$232,767

Of which drugs: $47,767

Medicare patients

508

Average age 76

Services billed

10,881

307 women, 201 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 63%
Depression 19%
Diabetes 18%
Atrial fibrillation 17%
Ischemic heart disease 16%
Osteoporosis 16%
Cancer 14%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg J7325 Office 96 6,240 $43,785
Injection, methylprednisolone acetate, 1 mg J1010 Office 48 2,720 $272
Injection, methylprednisolone acetate, 40 mg J1030 Office 12 12 $60

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

83 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Washington

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record